Delivery Order 36F79718D0414-36C77021N0199

Award Date 7/28/21
Potential Completion Date 7/30/21
Potential Value $678K
Contracting Federal Agency
Veterans Integrated Service Network 15
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a $652,376 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order calls for the delivery of VALBENAZINE 80MG capsules to the Hines VA Medical Center in Illinois. The one-week period of performance from November 3 to November 10, 2020 indicates this was likely an urgent order to treat veterans for a condition addressed by the medication. Neurocrine...
The Department of Veterans Affairs Veterans Health Administration awarded a $677,821.50 firm fixed price delivery order against the prime contractor Neurocrine Biosciences, Inc.'s Pharmaceuticals and Drugs GSA Schedule. This order is for the delivery of VALBENAZINE 80MG and 40MG oral capsules to facilities within Veterans Integrated Service Network 12. Neurocrine Biosciences will deliver the requested medications from its production location in San Diego, California by July 6, 2021 to support...
The Department of Veterans Affairs Veterans Health Administration awarded a $543,648 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The contract calls for Neurocrine to provide VALBENAZINE 80MG capsules to Veterans Integrated Service Network 12 in support of VA-VHA programs. Performance will take place in San Diego, California over a period of four days from September 22 to September 25, 2020. The firm fixed price contract...
The Department of Veterans Affairs Veterans Health Administration awarded a $840,641 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The contract calls for Neurocrine to provide VALBENAZINE to Veterans Integrated Service Network 12 in support of VA-VHA programs. Performance will take place in San Diego, California over a period of one week from January 3-10, 2020. The firm fixed price contract utilizes Neurocrine's existing...
The Department of Veterans Affairs Veterans Health Administration awarded a $529,050 firm fixed price delivery order against GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB) to Neurocrine Biosciences, Inc. to provide VALBENAZINE for Veterans Integrated Service Network 12. Performance will take place from May 19-22, 2020 in San Diego, California. This order was issued under the GSA Pharmaceuticals and Drugs schedule, a multiple award IDIQ contract vehicle, to supply the drug VALBENAZINE in...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price delivery order contract to Neurocrine Biosciences, Inc. to provide VALBENAZINE 40mg oral capsules. The contract, issued against Neurocrine's listing on the General Services Administration's Pharmaceuticals and Drugs schedule, has a potential value of $405,722.88. The VALBENAZINE capsules are used to treat neurological movement disorders and will be delivered to VA facilities, primarily within...
The Department of Veterans Affairs Veterans Health Administration awarded a $677,821.50 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Neurocrine Biosciences, Inc. for the supply of valbenazine oral capsules. Specifically, the contract calls for 30ct bottles of 40mg and 80mg valbenazine capsules, totaling approximately $677k. Performance will take place in San Diego, California over a period of 3 months concluding at the end of September 2021. The firm fixed...
The Department of Veterans Affairs awarded a firm fixed price delivery order contract to Neurocrine Biosciences, Inc., a biopharmaceutical company, to provide VALBENAZINE 40mg and 80mg oral capsules to the Veterans Health Administration. This contract was issued against Neurocrine's listing on the Pharmaceuticals and Drugs schedule contract under the General Services Administration's Multiple Award Schedule program. The $698,940.24 contract has no set-aside designation and is to support...
The Department of Veterans Affairs Veterans Health Administration awarded Neurocrine Biosciences, Inc. a $579,765.60 firm fixed price delivery order against the company's GSA Schedule Pharmaceuticals and Drugs contract. The contract calls for Neurocrine to provide VALBENAZINE to Veterans Integrated Service Network 12 in support of the VA-VHA's healthcare programs. Performance will take place in San Diego, California over a one week period in June 2020. No subcontractors or set aside designations...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Neurocrine Biosciences, Inc., a biopharmaceutical company, to provide VALBENAZINE capsules. The contract is issued against Neurocrine's General Services Administration (GSA) Multiple Award Schedule Pharmaceuticals and Drugs contract, with a potential value of $217,459.20. There was no set-aside designation for this award. Neurocrine has provided...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a $677,821.50 firm fixed price delivery order against Neurocrine Biosciences, Inc.'s Pharmaceuticals and Drugs GSA Schedule contract. This order is to provide VALBENAZINE 40MG and 80MG capsules for the Hines CMOP, indicating the capsules will support treatment programs at the Captain James A. Lovell Federal Health Care Center in Illinois. Neurocrine Biosciences will serve as the prime contractor, delivering the specified pharmaceutical products to the VA medical facility from their location in San Diego, California by July 30, 2021 to fulfill this order placed under the VA's Federal Supply Schedule program.

Generated 12/24/23, 11:21 PM